Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 15 October 2005, Vol. 106, No. 8, pp. 2827-2836.
Prepublished online as a Blood First Edition Paper on June 28, 2005; DOI 10.1182/blood-2005-01-0358.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Table
Right arrow All Versions of this Article:
2005-01-0358v1
106/8/2827    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gery, S.
Right arrow Articles by Koeffler, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gery, S.
Right arrow Articles by Koeffler, H. P.
Related Collections
Right arrow Neoplasia
Right arrow Gene Expression
Right arrow Genomics
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia

Sigal Gery, Adrian F. Gombart, William S. Yi, Chloe Koeffler, Wolf-K. Hofmann, and H. Phillip Koeffler

From the Cedars-Sinai Medical Center, Division of Hematology/Oncology, University of California (UCLA) School of Medicine, Los Angeles, CA; and the Department of Hematology and Oncology and Transfusion Medicine, University Hospital "Benjamin Franklin," Berlin, Germany.

CCAAT/enhancer-binding proteins (C/EBPs) are a family of transcription factors that regulate cell growth and differentiation in numerous cell types. To identify novel C/EBP-target genes, we performed transcriptional profiling using inducible NIH 3T3 cell lines expressing 1 of 4 members of the C/EBP family. Functional analysis revealed a previously unknown link between C/EBP proteins and circadian clock genes. Our microarray data showed that the expression levels of 2 core components of the circadian network, Per2 and Rev-Erb{alpha}, were significantly altered by C/EBPs. Recent studies suggested that Per2 behaves as a tumor suppressor gene in mice. Therefore, we focused our additional studies on Per2. We showed that Per2 expression is up-regulated by C/EBP{alpha} and C/EBP{epsilon}. Per2 levels were reduced in lymphoma cell lines and in acute myeloid leukemia (AML) patient samples. In addition, we generated stable K562 cells that expressed an inducible Per2 gene. Induction of Per2 expression resulted in growth inhibition, cell cycle arrest, apoptosis, and loss of clonogenic ability. These results suggest that Per2 is a downstream C/EBP{alpha}-target gene involved in AML, and its disruption might be involved in initiation and/or progression of AML. (Blood. 2005; 106:2827-2836)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Biol RhythmsHome page
M. Chen-Goodspeed and Cheng Chi Lee
Tumor Suppression and Circadian Function
J Biol Rhythms, August 1, 2007; 22(4): 291 - 298.
[Abstract] [PDF]

Home page
 J. Virol.Home page
K. Johung, E. C. Goodwin, and D. DiMaio
Human Papillomavirus E7 Repression in Cervical Carcinoma Cells Initiates a Transcriptional Cascade Driven by the Retinoblastoma Family, Resulting in Senescence
J. Virol., March 1, 2007; 81(5): 2102 - 2116.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Gery, N. Komatsu, N. Kawamata, C. W. Miller, J. Desmond, R. K. Virk, A. Marchevsky, R. Mckenna, H. Taguchi, and H. P. Koeffler
Epigenetic Silencing of the Candidate Tumor Suppressor Gene Per1 in Non-Small Cell Lung Cancer
Clin. Cancer Res., March 1, 2007; 13(5): 1399 - 1404.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. H. Ko and J. S. Takahashi
Molecular components of the mammalian circadian clock
Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R271 - R277.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. L. Brown, C. R. Wilkinson, S. R. Waterman, C. H. Kok, D. G. Salerno, S. M. Diakiw, B. Reynolds, H. S. Scott, A. Tsykin, G. F. Glonek, et al.
Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling
J. Leukoc. Biol., August 1, 2006; 80(2): 433 - 447.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020